Intraneuronal Pyroglutamate-Abeta 3–42 Triggers Neurodegeneration and Lethal Neurological Deficits in a Transgenic Mouse Model

Acta Neuropathologica - Germany
doi 10.1007/s00401-009-0557-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neonatal Neurodegeneration in Alzheimer’s Disease Transgenic Mouse Model

Journal of Alzheimer's Disease Reports
2018English

Wocko, a Neurological Mutant Generated in a Transgenic Mouse Pedigree

Journal of Neuroscience
Neuroscience
1991English

Caspase-3 Triggers Early Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease

Nature Neuroscience
Neuroscience
2010English

Apocynin Administration Does Not Improve Behavioral and Neuropathological Deficits in a Transgenic Mouse Model of Alzheimer's Disease

Neuroscience Letters
Neuroscience
2011English

-Amyloid Peptides Enhance -Synuclein Accumulation and Neuronal Deficits in a Transgenic Mouse Model Linking Alzheimer's Disease and Parkinson's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Passive Immunization Against Pyroglutamate-3 Amyloid-SS Reduces Plaque Burden in Alzheimer-Like Transgenic Mice: A Pilot Study

Neurodegenerative Diseases
Neurology
2012English

Transgenic Expression of Intraneuronal a 42 but Not a 40 Leads to Cellular a Lesions, Degeneration, and Functional Impairment Without Typical Alzheimer's Disease Pathology

Journal of Neuroscience
Neuroscience
2012English

Neurodegeneration and Inflammation: Analysis of a FTDP-17 Model Mouse

Clinical Neurology
Neurology
2008English

Restorative Effect of Endurance Exercise on Behavioral Deficits in the Chronic Mouse Model of Parkinson's Disease With Severe Neurodegeneration

BMC Neuroscience
NeuroscienceCellularMolecular Neuroscience
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy